tradingkey.logo
搜索

Danaher Corp

DHR
添加自选
179.030USD
+0.840+0.47%
收盘 06/23, 16:00美东报价延迟15分钟
126.70B总市值
34.48市盈率 TTM

Danaher Corp

179.030
+0.840+0.47%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.47%

5天

-1.14%

1月

+4.09%

6月

-21.48%

今年开始到现在

-21.79%

1年

-8.84%

关键数据
180.570今开
181.490最高
4.15M成交量
34.48市盈率 TTM
19.41市盈率动
1.360股息TTM
0.59%换手率
178.190昨收
177.070最低
399.47M成交额
32.50市盈率静
2.39市净率
0.76%股息率 TTM
4.52%ROA
242.80052周最高
1.02量比
3.90B净利润
707.70M总股本
5.1926每股收益TTM
0.81Beta
7.08%ROE
160.93052周最低
2.48%振幅
60.34%毛利率
126.70B总市值
2.36回报/风险
1.53%风险率

TradingKey Danaher Corp股票评分

单位: USD 更新时间: 2026-06-22

操作建议

Danaher Corp当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名29/203位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价240.06。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Danaher Corp评分

相关信息

行业排名
29 / 203
全市场排名
110 / 4577
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

38°C

过冷
过热
看空

Danaher Corp亮点

亮点风险
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
高分红
公司属于高分红公司,最新股息支付率20.13%
稳定分红
公司5年内连续分红,最新股息支付率20.13%
估值低估
公司最新PE估值34.32,处于3年历史低位
机构减仓
最新机构持股594.48M股,环比减少0.66%
阿尔·戈尔持仓
明星投资者阿尔·戈尔持仓,最新持仓市值7.97M

分析师目标

根据 28 位分析师
买入
评级
240.064
目标均价
+34.72%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Danaher Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Danaher Corp简介

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
公司代码DHR
公司Danaher Corp
CEOBlair (Rainer M)
网址https://www.danaher.com/

常见问题

Danaher Corp(DHR)的当前股价是多少?

Danaher Corp(DHR)的当前股价是 178.29。

Danaher Corp的股票代码是什么?

Danaher Corp的股票代码是DHR。

Danaher Corp股票的52周最高点是多少?

Danaher Corp股票的52周最高点是242.80。

Danaher Corp股票的52周最低点是多少?

Danaher Corp股票的52周最低点是160.93。

Danaher Corp的市值是多少?

Danaher Corp的市值是126.12B。

现在Danaher Corp(DHR)的股票是买入、持有还是卖出?

根据分析师评级,Danaher Corp(DHR)的总体评级为买入,目标价格为240.06。

Danaher Corp(DHR)股票的每股收益(EPS TTM)是多少

Danaher Corp(DHR)股票的每股收益(EPS TTM)是5.07。
KeyAI